Perseus Proteomics (TSE:4882) Change In Inventory: 円-1.8 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4882 Perseus Proteomics Inc TSE:4882
55 GF Score
Price 円147.00
GF Value 円441.71
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Perseus Proteomics Change In Inventory?

Perseus Proteomics TSE:4882 -0.68% 55 Change In Inventory is 円-1.8 Mil as of Mar. 2026. GuruFocus rates TSE:4882 with a GF Score™ of 55/100 and a GF Value™ of 円441.71 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Perseus Proteomics's change in inventory for the quarter that ended in Mar. 2026 was 円4.1 Mil. It means Perseus Proteomics's inventory declined by 円4.1 Mil from Sep. 2025 to Mar. 2026 .

Perseus Proteomics's change in inventory for the fiscal year that ended in Mar. 2026 was 円-1.8 Mil. It means Perseus Proteomics's inventory increased by 円1.8 Mil from Mar. 2025 to Mar. 2026 .

Perseus Proteomics's Total Inventories for the quarter that ended in Mar. 2026 was 円7.1 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Perseus Proteomics's Days Inventory for the quarter that ended in Mar. 2026 was 106.17.

Inventory Turnover measures how fast the company turns over its inventory within a year. Perseus Proteomics's Inventory Turnover for the quarter that ended in Mar. 2026 was 1.72.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Perseus Proteomics's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.12.

Perseus Proteomics  (TSE:4882) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Perseus Proteomics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=9.1855/15.789*365 / 2
=106.17

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Perseus Proteomics's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=15.789 / 9.1855
=1.72

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Perseus Proteomics's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=9.1855 / 74.544
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perseus Proteomics Change In Inventory Related Terms

Perseus Proteomics Change In Inventory Historical Data

* Premium members only.

The historical data trend for Perseus Proteomics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Perseus Proteomics Change In Inventory Chart

Perseus Proteomics Annual Data
Trend Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Inventory
Get a 7-Day Free Trial Premium Member Only -1.37 0.11 -1.23 -0.91 -1.81

Perseus Proteomics Semi-Annual Data
Mar18 Mar19 Mar20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.34 -1.11 0.21 -5.94 4.14
TSE:4882
55GF Score
Perseus Proteomics Inc TSE:4882
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Perseus Proteomics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円-1.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of 円-1.8 Mil mean?
Perseus Proteomics (TSE:4882) has a Change In Inventory of 円-1.8 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Perseus Proteomics and its competitors.
Is Perseus Proteomics' Change In Inventory too high?
Perseus Proteomics' current Change In Inventory is 円-1.8 Mil. Overall, Perseus Proteomics has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Perseus Proteomics' Change In Inventory compare to LLY and JNJ?
Perseus Proteomics' Change In Inventory of 円-1.8 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Drug Manufacturers company?
A good Change In Inventory depends on the Drug Manufacturers industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Perseus Proteomics and its competitors. Perseus Proteomics's current Change In Inventory is 円-1.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Perseus Proteomics stock overvalued right now?
Based on GuruFocus' analysis, Perseus Proteomics (TSE:4882) is currently considered Significantly Undervalued. The stock's GF Value™ is 円441.71, compared to a current price of 円147.00 — trading 66.7% below its estimated fair value. The current Change In Inventory is 円-1.8 Mil. Perseus Proteomics' overall GF Score™ is 55/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Perseus Proteomics (TSE:4882), the current Change In Inventory is 円-1.8 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Perseus Proteomics (TSE:4882) Overvalued in 2026?

Based on GuruFocus' analysis, Perseus Proteomics stock appears to be undervalued. The current stock price of 円147.00 is trading 66.7% below its estimated GF Value™ of 円441.71. GuruFocus considers Perseus Proteomics to be Significantly Undervalued.

Key valuation signals for TSE:4882:

  • Change In Inventory: 円-1.8 Mil
  • GF Value™: 円441.71 vs. price of 円147.00 (66.7% below fair value)
  • GF Score™: 55/100 with 1 warning sign

No single metric tells the full story. See the TSE:4882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Perseus Proteomics Business Description

Address 30-1 Hakozakicho, Nihonbashi, Chuo-ku, AiNihombashi EAST 3rd floor, Tokyo, JPN, 103-0015
Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody-based therapeutics and diagnostic drugs to cure cancer and other diseases. The Company operates in a single segment, the pharmaceutical business.
55GF Score

Get the complete analysis for TSE:4882

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円147.00
Price
円441.71
GF Value